The activity of the mTOR pathway, usually inhibited by p53, seems to be increased in some tissues of p53−/− mice with a tendency to elevated IGF-1 levels, but the effects of absence of p53 can be partially attenuated by rapamycin, leading to changes in tumor spectrum [29, 30]. Here, IGF1 is linked to neoplasm.